SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-025752
Filing Date
2021-05-10
Accepted
2021-05-10 07:02:04
Documents
67
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q logc-10q_20210331.htm   iXBRL 10-Q 1342923
2 EX-10.1 logc-ex101_30.htm EX-10.1 33772
3 EX-10.2 logc-ex102_29.htm EX-10.2 112552
4 EX-31.1 logc-ex311_7.htm EX-31.1 18749
5 EX-31.2 logc-ex312_9.htm EX-31.2 18490
6 EX-32.1 logc-ex321_11.htm EX-32.1 7597
  Complete submission text file 0001564590-21-025752.txt   5303225

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA logc-20210331.xsd EX-101.SCH 40261
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE logc-20210331_cal.xml EX-101.CAL 45523
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE logc-20210331_def.xml EX-101.DEF 102520
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE logc-20210331_lab.xml EX-101.LAB 320907
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE logc-20210331_pre.xml EX-101.PRE 235952
12 EXTRACTED XBRL INSTANCE DOCUMENT logc-10q_20210331_htm.xml XML 815806
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Filer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38707 | Film No.: 21905186
SIC: 2836 Biological Products, (No Diagnostic Substances)